MYLAN 2045 MYLAN 2045 (Tacrolimus 0.5 mg)

Pill with imprint MYLAN 2045 MYLAN 2045 is Orange / Gray, Capsule-shape and has been identified as Tacrolimus 0.5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Tacrolimus is used in the treatment of organ transplant, rejection prophylaxis; organ transplant, rejection reversal and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2045 MYLAN 2045

Save up to 80% off prescription medications

Click here for your free Discount Card

Tacrolimus

Imprint

MYLAN 2045 MYLAN 2045

Strength

0.5 mg

Color

Orange / Gray

Size

14.00 mm

Shape

Capsule-shape

Availability

Prescription only

Drug Class

Calcineurin inhibitors

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Mylan Pharmaceuticals Inc.

Inactive Ingredients

lactose anhydrous, ferrosoferric oxide, silicon dioxide, croscarmellose sodium, gelatin, hypromelloses, lactose monohydrate, magnesium stearate, sodium lauryl sulfate, titanium dioxide, ferric oxide yellow, D&C Red No. 28, D&C Yellow No. 10, FD&C Red No. 40, FD&C Blue No. 1, FD&C Blue No. 2, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00378-2045	Mylan Pharmaceuticals Inc.
51079-0817	UDL Laboratories Inc.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer